User profiles for Parakkal Deepak
 | Parakkal Deepak MBBS, MS, FACGAssociate Professor of Medicine, Div. of Gastroenterology, Washington University School of … Verified email at wustl.edu Cited by 4673 |
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis
Objectives The treatment for COVID-19 often utilizes immune-modulating drugs. These
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
[HTML][HTML] Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD—disease outcome and response to therapy
Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme
phenotypes, Crohn’s disease [CD] and ulcerative colitis [UC], which both represent numerous …
phenotypes, Crohn’s disease [CD] and ulcerative colitis [UC], which both represent numerous …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
Background: Patients with chronic inflammatory disease (CID) treated with immunosuppressive
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
medications have increased risk for severe COVID-19. Although mRNA-based SARS-…
Systematic review with meta-analysis: safety and effectiveness of combining biologics and small molecules in inflammatory bowel disease
…, BP Abraham, JF Colombel, P Deepak - Crohn's & Colitis …, 2022 - academic.oup.com
Background Combining biologics and small molecules could potentially overcome the plateau
of drug efficacy in inflammatory bowel disease (IBD). We conducted a systematic review …
of drug efficacy in inflammatory bowel disease (IBD). We conducted a systematic review …
Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice
Alterations of the mycobiota composition associated with Crohn’s disease (CD) are challenging
to link to defining elements of pathophysiology, such as poor injury repair. Using culture-…
to link to defining elements of pathophysiology, such as poor injury repair. Using culture-…
[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
with immunosuppressive medications that can increase their risk of severe COVID-19. While …
T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study
P Deepak, H Sifuentes, M Sherid… - Official journal of the …, 2013 - journals.lww.com
OBJECTIVES: The risk of non-Hodgkin's lymphoma (NHL) with tumor necrosis factor alpha (TNF-α)
inhibitors is unclear, whether related to concomitant thiopurines usage or due to the …
inhibitors is unclear, whether related to concomitant thiopurines usage or due to the …
Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn's disease
P Deepak, JG Fletcher, JL Fidler… - Official journal of the …, 2016 - journals.lww.com
OBJECTIVES: Crohn's disease (CD) management targets mucosal healing on ileocolonoscopy
as a treatment goal. We hypothesized that radiologic response is also associated with …
as a treatment goal. We hypothesized that radiologic response is also associated with …
[HTML][HTML] SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The …
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths. The …
